A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy Volunteers

NCT05116865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Respiratory Infection

Interventions

BIOLOGICAL: HH-120 Dose 1
BIOLOGICAL: HH-120 Dose 2
BIOLOGICAL: HH-120 Dose 3
DRUG: Placebo

Sponsor

Huahui Health